期刊文献+

蛋白激酶C-β与糖尿病肾病研究的进展 被引量:8

Advances of protein kinase C beta and diabetic nephropathy
下载PDF
导出
摘要 PRKCB1基因编码的蛋白激酶C(PKC)-βⅠ和PKC-βⅡ两种亚型,通过PKC信号通路途径在糖尿病肾病的发生和进展中起着重要作用。PKC-β抑制剂通过降低肾小球基膜的厚度和减少微量白蛋白尿,对糖尿病患者的肾脏起着保护作用。PRKCB1基因的多态或变异通过影响该基因的转录活性、增加胰岛素抵抗、促进血管内皮氧化应激,而与糖尿病肾病风险增加及终末期肾病相关。该文就PKC-β与糖尿病肾病关系的研究进展进行综述。 Two isoforms of protein kinase C (PKC), i.e. PKC-βⅠ and -βⅡ, which are encoded by the PRKCB1 gene, play important roles in the development and progression of diabetic nephropathy through the PKC signaling pathway. PKG-β inhibitor can reduce the thickness of glomerular basement membrane and microalbuminuria to protect the renal functions of diabetes patients. Polymorphisms and variants of PRKCB1 gene are relevant to increasing the risk of diabetic nephropathy and end stage renal disease by affecting its transcriptional activity, increasing insulin resistance, and promoting endothelial oxidative stress. This paper reviews the research progresses on the relationship between PKC-β and diabetic nephropathy.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2014年第4期551-555,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家自然科学基金(81270876 30771022 30971384) 上海市科委优秀学科带头人基金(10XD1403400)~~
关键词 蛋白激酶C-β 糖尿病肾病 PRKCB1基因 protein kinase C-β diabetic nephropathy PRKCB1 gene
  • 相关文献

参考文献31

  • 1Xu Y, Wang L, HeJ, et al. Prevalence and control of diabetes in Cbinese adults[J].JAMA, 2013, 310(9): 948 -959.
  • 2Alcorn T, Ouyang Y. Diabetes saps health and wealth from China's rise[J]. Lancet, 2012, 379(9833): 2227 -2228.
  • 3Levey AS, Coresb 1. Chronic kidney disease[J]. Lancet, 2012, 379(9811) : 165 -180.
  • 4Packham D K, Alves TP, DwyerJP, et al. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diahetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database[J]. AmJ Kidney Dis, 2012, 59 (1) : 75 - 83.
  • 5Liu Y, Lei S, Gao X, et al. PKCbeta inhibition with ruhoxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes[J] . Clin Sci (Lond), 2012,122(4): 161 -173.
  • 6Suh YJ, Kim S, Kim SH, et al. Comhined genome-wide linkage and association analyses of fasting glucose level in healthy twins and families of Korea[J].J Korean Med Sci, 2013, 28 ( 3) : 415 - 423.
  • 7Araki S, Haneda M, Sugimoto T, et al. Polymorphisms of the protein kinase C-[3 gene (PRKCBI) accelerate kidney disease in type 2 diabetes without overt proteinuria[J]. Diabetes Care, 2006, 29 ( 4) : 864 - 868.
  • 8Ma RC, Tam CH, Wang Y, et al. Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes[J].JAMA, 2010, 304 (8) : 881 - 889.
  • 9GreenhamJ, Adams M, Doggett N, et al. Elucidation of the exon?intron structure and size of the human protein kinase C beta gene (PRKCB)[J]. Hum Genet, 1998, 103 (4) : 483 - 487.
  • 10Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications[J]. Circ Res, 2010, 106 (8) : 1319 -1331.

同被引文献145

引证文献8

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部